Page 83 - GPD-2-2
P. 83
Gene & Protein in Disease Genetics of arteriovenous malformations
100. Al-Samkari H, Eng W, 2022, A precision medicine approach malformations. Stroke, 37(1): 231–234.
to hereditary hemorrhagic telangiectasia and complex https://doi.org/10.1161/01.STR.0000195133.98378.4b
vascular anomalies. J Thromb Haemost, 20(5): 1077–1088.
109. Kim H, Hysi PG, Pawlikowska L, et al., 2008, Population
https://doi.org/10.1111/jth.15715
stratification in a case-control study of brain arteriovenous
101. Nicholson CL, Flanagan S, Murati M, et al., 2022, Successful malformation in latinos. Neuroepidemiology, 31(4): 224–228.
management of an arteriovenous malformation with
trametinib in a patient with capillary-malformation https://doi.org/10.1159/000160215
arteriovenous malformation syndrome and cardiac 110. Zhao Y, Li P, Fan W, et al., 2010, The rs522616 polymorphism
compromise. Pediatr Dermatol, 39(2): 316–319. in the matrix metalloproteinase-3 (MMP-3) gene is
https://doi.org/10.1111/pde.14912 associated with sporadic brain arteriovenous malformation
in a Chinese population. J Clin Neurosci, 17(12): 1568–1572.
102. Zhu W, Chen W, Zou D, et al., 2018, Thalidomide reduces
hemorrhage of brain arteriovenous malformations in a https://doi.org/10.1016/j.jocn.2010.04.023
mouse model. Stroke, 49(5): 1232–1240. 111. Fontanella M, Rubino E, Crobeddu E, et al., 2012,
https://doi.org/10.1161/STROKEAHA.117.020356 Brain arteriovenous malformations are associated with
interleukin-1 cluster gene polymorphisms. Neurosurgery,
103. Chen W, Guo Y, Walker EJ, et al., 13, Reduced mural cell 70(1): 12–17.
coverage and impaired vessel integrity after angiogenic
stimulation in the Alk1-deficient brain. Arterioscler Thromb https://doi.org/10.1227/NEU.0b013e31822d9881
Vasc Biol, 33(2): 305–310. 112. Kim H, Hysi PG, Pawlikowska L, et al., 2009, Common variants
https://doi.org/10.1161/ATVBAHA.112.300485 in interleukin-1-beta gene are associated with intracranial
hemorrhage and susceptibility to brain arteriovenous
104. McLaren O, Ronan N, 2019, Recurrent epistaxis in an malformation. Cerebrovasc Dis, 27(2): 176–182.
adolescent. BMJ, 2019: l5393.
https://doi.org/10.1159/000185609
https://doi.org/10.1136/bmj.l5393
113. Song M, Bai H, Zhang P, et al., 2023, Promising applications
105. Agarwal N, Schalet G, Shah M, et al., 2012, Endovascular of human-derived saliva biomarker testing in clinical
management of cerebral arteriovenous malformations in diagnostics. Int J Oral Sci, 15(1): 2.
pregnancy: Two case reports and a review of the literature.
J Neurol Res, 2: 215–220. https://doi.org/10.1038/s41368-022-00209-w
https://doi.org/10.4021/jnr148w 114. Shanthikumar S, Bekhit E, Bracken J, 2023, MRI as
screening for pulmonary arteriovenous malformations in
106. El Sissy FN, Wassef M, Faucon B, et al., 2022, Somatic hereditary hemorrhagic telangiectasia. Pediatr Pulmonol,
mutational landscape of extracranial arteriovenous 58(4): 1281–1282.
malformations and phenotypic correlations. J Eur Acad
Dermatol Venereol, 36(6): 905–912. https://doi.org/10.1002/ppul.26297
https://doi.org/10.1111/jdv.18046 115. McDonald J, Bayrak-Toydemir P, Pyeritz RE, 2011,
Hereditary hemorrhagic telangiectasia: An overview of
107. Ota T, Komiyama M, 2020, Pathogenesis of non-hereditary diagnosis, management, and pathogenesis. Genet Med,
brain arteriovenous malformation and therapeutic 13(7): 607–616.
implications. Interv Neuroradiol, 26(3): 244–253.
https://doi.org/10.1097/GIM.0b013e3182136d32
https://doi.org/10.1177/1591019920901931
116. Vollherbst DF, Bendszus M, Möhlenbruch MA, 2020,
108. Achrol AS, Pawlikowska L, McCulloch CE, et al., 2006, Vascular malformations of the brain and its coverings.
Tumor necrosis factor-α–238G>A promoter polymorphism
is associated with increased risk of new hemorrhage in J Neuroendovascular Ther, 14(8): 285–294.
the natural course of patients with brain arteriovenous https://doi.org/10.5797/jnet.ra.2020-0020
Volume 2 Issue 2 (2023) 17 https://doi.org/10.36922/gpd.0312

